scispace - formally typeset
K

Kazuhide Yamamoto

Researcher at Okayama University

Publications -  482
Citations -  12159

Kazuhide Yamamoto is an academic researcher from Okayama University. The author has contributed to research in topics: Hepatocellular carcinoma & Autoimmune hepatitis. The author has an hindex of 52, co-authored 479 publications receiving 10842 citations. Previous affiliations of Kazuhide Yamamoto include Shiga University of Medical Science.

Papers
More filters
Journal ArticleDOI

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

TL;DR: Interferon‐free, ribavirin‐free all‐oral therapy with daclatasvir and asunaprevir for 24 weeks is well tolerated and can achieve a high rate of SVR in patients with HCV genotype 1b who were ineligible, intolerant, or had not responded to prior interferon-based therapy.
Journal ArticleDOI

Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)

TL;DR: Targeting mitochondrial oxidative stress might be a good candidate for NASH treatment because molecular hydrogen is an effective antioxidant that reduces only cytotoxic reactive oxygen species (ROS) and several diseases associated with oxidative stress are sensitive to hydrogen.
Journal ArticleDOI

Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.

Minoru Nakamura, +79 more
TL;DR: Observations indicated the existence of ethnic differences in genetic susceptibility loci to PBC and the importance of TNF signaling and B cell differentiation for the development of PBC in individuals of European descent and Japanese individuals.
Journal ArticleDOI

The presence of large serrated polyps increases risk for colorectal cancer.

TL;DR: The presence of large serrated polyps is a risk factor for colorectal cancer, particularly CRC of the proximal colon, and the presence of LSPs was the greatest risk factors for CRC.
Journal ArticleDOI

Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer.

TL;DR: The clinical usefulness of genetic analysis for ctDNA by digital polymerase chain reaction in patients with pancreatic cancer is estimated.